XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Long-term Debt
 3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Long-term Debt Long-term Debt
Our long-term debt outstanding consists of the following (in millions):
March 31, 2022December 31, 2021
Credit Agreement—  
Advances under revolving credit facility$305.0 $200.0 
Term loan facilities235.3 238.5 
Bonds payable—
5.125% Senior Notes due 2023
— 99.6 
5.75% Senior Notes due 2025
347.2 347.0 
4.50% Senior Notes due 2028
779.5 786.8 
4.75% Senior Notes due 2030
777.2 784.7 
4.625% Senior Notes due 2031
389.9 393.7 
Other notes payable49.0 49.6 
Finance lease obligations381.0 386.8 
3,264.1 3,286.7 
Less: Current portion(42.8)(42.8)
Long-term debt, net of current portion$3,221.3 $3,243.9 
On December 9, 2021, we announced the commencement of a consent solicitation of holders of our 5.75% Senior Notes due 2025, 4.50% Senior Notes due 2028, 4.75% Senior Notes due 2030, and 4.625% Senior Notes due 2031 (collectively the “Senior Notes”) for the adoption of certain amendments to an indenture (the “Base Indenture”) dated as of December 1, 2009, as supplemented by each Senior Notes’ respective supplemental indenture (together with the Base Indenture, the “Indenture”), which will provide us with greater flexibility in effecting the spin off discussed in Note 1, Basis of Presentation. Each Indenture contains restrictive covenants that, among other things, limit our ability and the ability of certain of our subsidiaries to make certain asset dispositions, investments, and distributions to holders of our capital stock. The amendments to the Indentures permit us, subject to the leverage ratio condition set forth below, to distribute to our equity holders in one or more transactions (a “Distribution”) some or all of the common stock of a subsidiary that holds substantially all of the assets of our home health and hospice business. We may make any such distribution so long as the Leverage Ratio (as defined in each Indenture) is no more than 3.5 to 1.0 on a pro forma basis after giving effect thereto. The amendments also reduce the capacity under our restricted payments builder basket under each existing Indenture by $200 million and amends the definition of “Consolidated Net Income” to allow us to exclude from Consolidated Net Income (a component of the Leverage Ratio) any fees, expenses or charges related to any Distribution and the solicitation of consents from the holders of the Senior Notes. In December 2021 and January 2022, we received the requisite consents for the adoption of these amendments. Under the terms of the amendments, we agreed to pay the holders of the Senior Notes a total of $40.5 million, excluding fees. We paid $20 million of this amount in January 2022. The remaining payment is contingent upon the execution of a Distribution and will be paid at such time.
In March 2022, we redeemed the remaining $100 million in outstanding principal amount of the 5.125% Senior Notes due 2023 (the “2023 Notes”) using capacity under our revolving credit facility. Pursuant to the terms of the 2023 Notes, this optional redemption was made at a price of par. As a result of this redemption, we recorded an aggregate $0.3 million Loss on early extinguishment of debt during the three months ended March 31, 2022.